Daniel Harari

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 3

Top Topics

Dendritic Cells

Epidermal Growth Factor Receptor

Chronic Lymphocytic Leukemia

Top Venues

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Maya Shemesh, Turgut E Aktepe, Joshua M Deerain, Julie L McAuley, Michelle D Audsley, Cassandra T David, Damian F J Purcell, Victoria Urin, Rune Hartmann, Gregory W Moseley, Jason M Mackenzie, Gideon Schreiber, Daniel Harari
SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon. PLoS pathogens 17 (8) (2021)
Meihui Xia, Tina Yuxuan Luo, Yonghong Shi, Guizhi Wang, Hubert Tsui, Daniel Harari, David E Spaner
Effect of Ibrutinib on the IFN Response of Chronic Lymphocytic Leukemia Cells. Journal of immunology (Baltimore, Md. : 1950) 205 (10) (2020)
Etai Rotem, Omri Faingold, Meital Charni, Yoel A Klug, Daniel Harari, Liraz Shmuel-Galia, Alon Nudelman, Varda Rotter, Yechiel Shai
The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in mice. PLoS pathogens 14 (5) (2018)